Study Details

General Information

Verily Diabetic Retinopathy 101703

A Multicenter Study to Evaluate the Performance of Automated Retinal Disease Assessment Software for the Detection of More Than Mild Diabetic Retinopathy (ARDA mtmDR study)

Protocol101703
IdentifierNCT04905459
UIDd0a3bdcf-a939-4973-9aeb-55e24ad969d1
StatusDone - Archived
PhasePivotal
Category / Adult
Launch Year0
NCT Number-
Created2021-05-25 12:58
Last Updated2022-06-15 17:36

Description

No description provided.

Comment

No comment.

Target Dates

NameDateRequired
Enrollment Closed2022-05-17No
Enrollment Open2022-02-09No
First Patient First VisitNo
Site Initiation Mtg.2022-01-26No
PI Meeting StartNo
PI Meeting EndNo
PI Meeting ArrivalNo
PI Meeting DepartureNo
Closeout Date2022-06-09No
Final PatientVisitNo
PreStudy Selection VisitNo
Target Date 12No
Target Date 13No
Target Date 14No

Leadership

RoleStaffLoginRequired
PrincipalMohseni, RizwanaRMohseniNo
RecruiterMiss, SalomonSMissNo
CoordinatorArmendariz, RocioRArmendarizNo
RegulatoryRamirez, ClaudiaCRamirezNo

Custom Fields

No custom fields.

Sponsor & Organization

SponsorVerily Life Sciences LLC
DivisionVerily Life Sciences LLC
TeamVerily Life Sciences LLC
Managing SiteCatalina Research Institute, LLC
Organization

Contacts

IRB Ref
CROEmmes
CRO Ref
Correspondence0

Opportunity

Probability0
Comment
Status ColorGainsboro
Currency-
Mayra Sibley

2 Hours

Hi there, I'm Jesse and you?
You

3 minutes

My name is Anne Clarc.
Mayra Sibley

40 seconds

Nice to meet you Anne.
How can i help you?